Bayshore HealthCare

Bayshore HealthCare

Founded in 1966, Bayshore HealthCare is a privately held Canadian healthcare provider headquartered in Mississauga, Ontario. The company offers home care, government-funded healthcare services, insurer and employer programs, and patient assistance programs (PAPs) for pharmaceutical manufacturers. The company's services span multiple therapeutic areas: oncology (lung cancer, breast cancer, colorectal cancer, chronic myelogenous leukemia, lymphoma), neurology (Alzheimer's disease, multiple sclerosis, ALS), rheumatology (rheumatoid arthritis, Crohn's disease, plaque psoriasis), and rare diseases (Gaucher disease, Fabry disease, hemophilia, Duchenne muscular dystrophy). Bayshore has developed a digital platform called Bayshore Digital Gateway for patient care. Its geographic footprint is entirely within Canada, serving national and provincial government funders and a network of pharmaceutical partners. Bayshore has operated for over 50 years and employs caregivers across Canada. The company's website references a Neighborhood Health Teams initiative launched in 2025, expanding its community-based care model. There is no publicly disclosed total deployment, professional count, or AUM for the parent company. Bayshore operates as an operating company, not a traditional investment vehicle. Its structural differentiator is its role as a healthcare services platform that manages patient access and treatment adherence for drug manufacturers, positioning it within Canada's specialized healthcare logistics space.